Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer - PubMed (original) (raw)
. 1992 Nov 15;52(22):6182-7.
Affiliations
- PMID: 1384957
Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer
A P Verhagen et al. Cancer Res. 1992.
Abstract
In the epithelium of secretory acini of the prostate two different cell types can be discriminated on the basis of localization, morphology, and degree of differentiation, the luminal and basal cells. The possibility of a developmental relationship between basal and luminal cells has been a subject of interest in several studies. According to the stem cell model at least three cell types, i.e., stem, amplifying, and transit cells, can be discriminated in the epithelium of prostate secretory acini. We previously reported that in the process of degeneration and regeneration in normal rat prostate a population of cells could be identified as candidates for the amplifying cells. These cells showed a keratin expression profile intermediate between those of basal and luminal cells. We now show, by using keratin antibodies, that also in normal human prostate at least three subpopulations of cells can be identified, one of them putatively representing amplifying cells as defined in the stem cell model. Furthermore, these antibodies were used to obtain a better insight into the different cell types involved in the etiology and progression of prostatic carcinoma. Both primary and hormone-independent prostatic tumors were investigated. Our results indicated that the candidate stem cell population was absent in prostatic carcinoma. Unlike earlier reports on the unique presence of cells with luminal characteristics in prostatic carcinoma, we identified also a population of cells coexpressing basal and luminal cell-type cytokeratins in primary and hormone-independent prostatic carcinoma. Since amplifying cells are defined in the stem cell model as precursors of transit (luminal) cells in the hierarchical pathway of prostatic epithelium differentiation, we postulate that on the basis of the keratin expression profile this subpopulation is most likely the target for neoplastic transformation.
Similar articles
- Changes in keratin expression during the development of benign prostatic hyperplasia.
Xue Y, Smedts F, Umbas R, Aalders TW, Debruyne FM, de la Rosette JJ, Schalken JA. Xue Y, et al. Eur Urol. 1997;32(3):332-8. Eur Urol. 1997. PMID: 9358223 - Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H, Remberger K. Bonkhoff H, et al. Prostate. 1996 Feb;28(2):98-106. doi: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J. Prostate. 1996. PMID: 8604398 Review. - Expression of basal cell keratins in human prostate cancer metastases and cell lines.
van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA. van Leenders GJ, et al. J Pathol. 2001 Dec;195(5):563-70. doi: 10.1002/path.993. J Pathol. 2001. PMID: 11745692 - [New aspects in histogenesis of hyperplasia and cancers of the prostate].
Bonkhoff H, Remberger K. Bonkhoff H, et al. Verh Dtsch Ges Pathol. 1993;77:31-9. Verh Dtsch Ges Pathol. 1993. PMID: 7511302 Review. German.
Cited by
- Identification of a cell of origin for human prostate cancer.
Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Goldstein AS, et al. Science. 2010 Jul 30;329(5991):568-71. doi: 10.1126/science.1189992. Science. 2010. PMID: 20671189 Free PMC article. - Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.
Yan J, Erdem H, Li R, Cai Y, Ayala G, Ittmann M, Yu-Lee LY, Tsai SY, Tsai MJ. Yan J, et al. Cancer Res. 2008 Jul 1;68(13):5460-8. doi: 10.1158/0008-5472.CAN-08-0955. Cancer Res. 2008. PMID: 18593949 Free PMC article. - Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors.
Peehl DM, Leung GK, Wong ST. Peehl DM, et al. Cell Tissue Res. 1994 Jul;277(1):11-8. doi: 10.1007/BF00303075. Cell Tissue Res. 1994. PMID: 7519968 - ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.
Feng W, Ladewig E, Salsabeel N, Zhao H, Lee YS, Gopalan A, Lange M, Luo H, Kang W, Fan N, Rosiek E, de Stanchina E, Chen Y, Carver BS, Leslie CS, Sawyers CL. Feng W, et al. bioRxiv [Preprint]. 2024 Apr 6:2023.05.15.540839. doi: 10.1101/2023.05.15.540839. bioRxiv. 2024. PMID: 38585869 Free PMC article. Preprint. - Prostate Cancer Stem Cells: Research Advances.
Jaworska D, Król W, Szliszka E. Jaworska D, et al. Int J Mol Sci. 2015 Nov 17;16(11):27433-49. doi: 10.3390/ijms161126036. Int J Mol Sci. 2015. PMID: 26593898 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical